National Institute Of Pharmaceutical Education And Research Kolkata

The government's most recent Pharmacy ranking scores NIPER Kolkata 84.73 on teaching, learning and resources, the best mark any of the seven NIPERs earned, and 31.61 on research and professional practice, the worst. Rank 29 is what a strong teaching score and a weak research score produce together, and the gap between the two is the most useful thing on this institute's card.

Two other facts decide a preference here. One of the ten programmes that admitted in the last round, M.Tech. Medical Technology, runs at no other NIPER in India and is the only block on the Kolkata grid with no monthly fellowship attached. And the institute is spread across three addresses: teaching at Chunilal Bhawan on Maniktala Main Road, a hostel on the other side of Kolkata at Salt Lake, and a permanent campus at Panihati whose foundation stone went down in 2023.

The institute is an Institute of National Importance created in 2007 under the Department of Pharmaceuticals in the Ministry of Chemicals and Fertilizers, and it opened narrow: three M.S. (Pharm.) disciplines only, Medicinal Chemistry, Natural Products and Pharmacoinformatics, on its about page. Pharmacology and Toxicology followed in 2018 and Pharmaceutics in 2020. Doctoral work began in the academic year 2016, in the same three founding subjects, before picking up the two newer ones. That history accounts for five of the ten disciplines admitting here today and stops at 2020; the rest arrived without a date anywhere on the institute's own record.

The second address is the one nobody quotes and the one most likely to change what a two year enrolment feels like. Union Minister Dr. Mansukh Mandaviya laid the foundation stone of a new campus at Panihati in North 24 Parganas on 25 August 2023, announcing 78 crore rupees for the permanent campus and a further 100 crores to build a centre of excellence, in a release issued that evening by the Press Information Bureau in Kolkata. The reason the release gives is space: the institute is planning to expand its facilities, more room is needed, so the second campus goes up in the city's northern suburb. The national admission brochure now describes the institute as holding campuses at both Maniktala and Panihati, in the NIPER JEE 2026 Masters information brochure, without saying what is taught where. That sentence is the one to put back to the registrar in writing, naming your discipline, before an offer is accepted.

Its intake is national rather than Bengali, and by a long way. West Bengal supplied 27 of the 206 students on the two year postgraduate roll, the other 179 arrived from elsewhere in India, and nobody at all came from abroad, in the institute's NIRF 2026 data submission. That same return splits the roll 119 men to 87 women and puts 79 full time doctoral scholars behind it. A candidate from Kolkata gets no home advantage in the entrance process, and four in every five classmates will have moved for the seat.

Ten disciplines admitted here in the 2026-27 round, six under the M.S. (Pharm.) label and four under M.Tech., in the NIPER JEE 2026 seat matrix for masters programmes and the Masters information brochure that governs it. The last row of the table below is the one to read first, because it is the only one on this campus where the degree arrives without money.

M.Tech. Medical Technology runs at Kolkata and nowhere else. The course availability tables in the Masters information brochure tick it for this institute and cross it out for the other six, and the row exists only in the without fellowship table; there is no funded version of it anywhere in the system. The one campus in India that teaches this degree offers it without a stipend. Two other disciplines here are scarce rather than unique: Pharmacoinformatics runs at Hyderabad, Mohali and Kolkata alone, and Natural Products at those three plus Ahmedabad, in the same seat availability tables.

Before you plan around any of that, know that the institute's own site disagrees with the counselling grid. Its academic programme page lists eight postgraduate disciplines rather than ten, puts Medicinal Chemistry at 19 seats and Pharmaceutics at 20, and carries neither M.Tech. Biotechnology nor M.Tech. Medical Technology at all. Whatever that page is describing, it is not the round you would be applying to. The seat matrix published before counselling is the only list that governs an allotment.

There is no NIPER Kolkata fee schedule. What exists is one national schedule that this campus bills against, broken into a long list of separate one time and per semester heads, and the reason no two aggregators quote the same annual figure for Maniktala is that each of them totals a different subset of those heads.

Three of those heads are optional, and one Kolkata charge is not in the table at all. Hostel admission of ₹3,496, hostel rent of ₹4,593 and electricity of ₹5,500 come off the bill for a student who declines a room, in the same brochure, and that clause is genuinely usable here because the campus sits inside a city large enough to live in. The charge the table omits is stated in the Kolkata section of that brochure instead: this institute levies a miscellaneous fee for the transport it arranges between the hostel and the institute. Whichever way you go, a Kolkata commute is part of the price.

A doctorate is billed on the same heads at different rates, and almost the whole gap is bench and bed. Set the Ph.D. information brochure beside the Masters information brochure and the laboratory head runs ₹22,960 a semester against ₹11,483, the hostel room ₹7,654 against ₹4,593, and hostel admission ₹5,162 against ₹3,496, while tuition sits unchanged at ₹26,022 in both. That is what lifts a doctoral semester to ₹71,705 from the taught degree's ₹57,167, and the opening payment to ₹1,22,367 from ₹1,05,663, with ₹45,683 and ₹96,345 in the column where tuition reads nil. Thesis evaluation is charged separately at submission, which belongs in a budget for the far end of a doctorate rather than the near end. USD 3,250 at admission and USD 2,075 for each semester after it is the doctoral price for a foreign national, who is treated as a hosteller even after declining a room.

One price list here belongs to nobody enrolled. Anyone coming for a short training or internship pays by duration on the institute's training fee page: ₹10,000 a month for one or two months, ₹25,000 flat for three, ₹50,000 for six and ₹75,000 for nine, with the in between durations billed as the last flat block plus ₹10,000 for each remaining month. That card is worth knowing about even if you are applying for a degree, because a short training placement is the one arrangement here that an entrance rank plays no part in.

Nothing about getting in is decided in Kolkata. Admission here is an output of the common NIPER JEE process, administered from Mohali, and this institute's involvement starts only once a candidate has typed its name into a preference order, per the NIPER JEE 2026 Masters information brochure. The institute's own admissions page adds nothing current to that, describes admission as GPAT followed by NIPER JEE and still carries a 2023 announcement as its latest notice, so use the NIPER JEE portal for dates.

The scorecard and the marksheet are both filters, and both sit in front of the entrance result rather than behind it.

Which of the ten Kolkata doors is open to you depends entirely on the degree already in your hand, and the spread is unusually wide because four of the ten programmes are M.Tech. degrees. The table below reads the subject wise eligibility in section 2.1 of that brochure against the disciplines this campus actually offered.

Count the rows before you rank this institute high. A B.Pharm. graduate can compete for all ten and nobody else can. An M.Sc. in organic chemistry reaches four of them. An engineering degree reaches the four M.Tech. programmes and Pharmacoinformatics, and only in the right branch, which puts the campus's one unfunded programme squarely in an engineer's path. One group skips the paper altogether: candidates holding a foreign passport, and OCI or PIO card holders carded after 4 March 2021, are exempted from the entrance test and apply through the Study in India portal instead, in section 2.10 of the Masters information brochure. No student on this campus's most recent roll came from outside the country.

One sitting decides all of it, and three fifths of that sitting is pharmacy. The NIPER JEE paper runs 150 minutes over 200 multiple choice questions, 120 of them drawn mainly from the B.Pharm. syllabus, each worth half a mark with 0.125 docked for a wrong answer, and the form costs ₹4,000 to submit or ₹2,000 under SC and ST reservation, in the Masters information brochure. Set that against the eligibility table above and the asymmetry is obvious: every discipline here except Pharmaceutics is open to graduates who never read pharmacy, and all of them sit the same pharmacy paper.

What this campus does run itself is the tail end of admission, and it publishes the paperwork. Its student notices carry a schedule for physical reporting and document verification for the 2026-27 session at the top of the list, hostel room allotment circulars for newly admitted postgraduate and doctoral students, a final reporting deadline, and a notice for spot counselling of vacant seats at NIPER Kolkata. The outcome of that round goes on a different page: two notices carrying the results of online spot counselling sit on the institute's news page, so an applicant left out of the national phases has to watch both lists.

Doctoral entry runs on a different split, and its deciding stage happens at the other end of the country. Fifteen per cent of a doctoral candidate's combined merit comes from an interview that must be attended in physical mode at NIPER Mohali, the remaining 85% from the written test, in the NIPER JEE 2026 Ph.D. information brochure. Nobody from Maniktala who would actually supervise the research sits on that panel, and it is the only face to face stage in the whole process.

No closing rank exists for this campus, from the institute or from the counselling office, so any category wise cutoff table you meet for NIPER Kolkata was built by whoever is displaying it. What does get published, before every round, is the sheet of seats still unfilled, and the Kolkata page of those sheets is unusually revealing because this campus stayed on them to the end.

Two disciplines account for most of what would not fill, and only one of them is the obvious candidate. Medical Technology behaved exactly as an unfunded programme behaves: 18 of its 20 places were still open after the first phase and 9 of them survived all four, on the phase II and phase IV sheets. Natural Products is the surprise. It is a funded programme, it is one of the three subjects this institute opened with in 2007, it has only 10 seats, and 8 of them were still vacant going into phase II, 5 into phase III and 4 into phase IV. The oldest department on the campus was the hardest one to fill.

M.Tech. Biotechnology went the wrong way between rounds, and that says something the totals hide. Its Kolkata vacancy count rose from 3 before phase II to 6 before phase III, on the phase II and phase III sheets, which happens when candidates already holding those seats upgrade out of them. Four of those six went during phase III, leaving 2 on the phase IV sheet.

For an unreserved candidate the practical instruction is the opposite of the one a campus that fills early would give you. Seats in most Kolkata disciplines were still on the sheet in the third and fourth rounds, so an offer here can usually be held while an upgrade elsewhere is chased. Pharmacoinformatics is the exception. Only 1 of its 8 places was left when phase II opened, and it showed zero vacancies on both the phase III and phase IV sheets, the only Kolkata discipline that was full at both. That is the one queue to convert on sight.

Pay at this campus is described by exactly one number, and it is a middle rather than an average. ₹5,10,000 was the median filed for the 2024-25 batch, out of which 77 of 111 on-time finishers took a job and 11 went on to study further, in its NIRF 2026 data submission. No mean and no top offer appears anywhere in that filing or on any page of the institute's website to set beside it.

The pay line has flattened just as the cohort has doubled. The median climbed steeply from ₹3,80,000 to ₹5,05,000 across three cycles and then barely shifted, reaching ₹5,10,000, while the graduating class went from 49 to 111 over the same stretch, in the NIRF 2025 and NIRF 2026 submissions. More graduates are being placed each year and the middle of the market has stopped moving for them.

The higher studies column is where something changed abruptly. It ran 15, 19 and 23 across three cycles and then fell to 11 in 2024-25, in the NIRF 2026 data submission, against a cohort that was the largest the institute has ever graduated. Fewer than one leaver in ten went on to research in the most recent year, on a campus whose entire intake is a research masters, and that is worth raising with a department before you accept a seat intended as a route to a doctorate.

Employers are named, but only in the national brochure and only with a ceiling rather than a distribution. Recent leavers went to Biocon in Bangalore, Aragen, Audree of the Hetero group, Airis Pharma, Vivo Biotech, Natco, Sci Life Science and Ferring Pharma in Hyderabad, WNS in Gurgaon, Jubilant, Sravathi, MC Analytics and Suven Life Sciences in Bangalore, TCG Life Science in Kolkata and Macleod in Mumbai, with a package of up to 6 lakh a year, in the NIPER JEE 2026 Masters information brochure. Read that list geographically before you read it for the money. TCG Life Science is the only Kolkata name on it and the only one anywhere in eastern India; everything else is Hyderabad, Bangalore, Gurgaon or Mumbai. Studying pharmacy in Kolkata does not appear to mean working in Kolkata afterwards.

The institute publishes no placement report of its own. The Placement entry in its site footer is an anchor with an empty destination, there is no placement cell page anywhere on the site, and the recruiter names above exist only in a document produced at Mohali. A candidate sponsored by a government department or a pharmaceutical employer is outside all of it in any case, since a sponsored candidate is excluded from the financial assistance and placement provisions in the same brochure.

Reservation is applied inside each discipline here rather than across the intake as a whole, so the grid below is what an allotment is actually drawn from. The fellowship split does not run through it: nine blocks are funded and one is not.

Six of the ten disciplines carry no ST seat at all, because an intake of 8, 10 or 12 does not divide far enough to produce one. Six more places sit above that grid for candidates with benchmark disabilities, 5 of them attached to the funded blocks and 1 to Medical Technology, in the same matrix. Three further quotas are written into the national rules instead, and none of them appears on any Kolkata document.

The doctoral grid is where Kolkata stands alone among the seven, and not in a good way. The 2026 round gave this institute no institute funded doctoral seat whatsoever. Its entire doctoral allocation of 7 places sits in the project funded half of the NIPER JEE 2026 Ph.D. seat matrix, two each in Natural Products and Pharmaceutics and one each in Medicinal Chemistry, Pharmacology and Toxicology and Medical Devices, every one of them tied to a three year project. Ahmedabad, Guwahati, Hajipur, Hyderabad, Mohali and Raebareli all appear in the institute funded list on the first page of that document and Kolkata does not. A place tied to a project is a place tied to that project's money and its timeline, so ask which grant funds the seat you are offered.

Two different numbers describe how big this campus is, and they point in opposite directions. Its ranking return files 100 approved places for 2024-25, down from 111 a year earlier, in the NIRF 2026 data submission. The counselling grid issued the following cycle carried 120, in the seat matrix. The 20 place difference is exactly the unfunded Medical Technology block, which is one way to widen an intake without widening the fellowship bill behind it.

Twenty-ninth in 2025 on a score of 59.12, five places below where this institute stood a year earlier, in the pharmacy table the Ministry of Education publishes each year. The route to that position has a hole in the middle of it.

The 2022 row is not a formatting accident. The institute has an entry in the 2021 table and another in the 2023 table, and no entry anywhere in the 2022 one, which carries all six of its sibling institutes and not this one. Its best position so far was 24 in 2024, and it gave five of those places back in 2025 even though its own score rose from 58.76 to 59.12, which is what happens when the institutes around you improve faster than you do.

Research is doing the moving and it started from almost nothing. The research parameter was 13.74 in 2021, 13.87 in 2023, 26.83 in 2024 and 31.61 in 2025, so the whole gain arrived in the last two editions after two flat ones. Graduation outcomes rose almost 19 points across the same five tables, which fits a campus placing a rising share of a growing cohort. Two parameters went backwards: outreach and inclusivity fell from 63.71 to 55.34, and perception from 39.24 to 34.87 after peaking at 40.57 in 2023.

Set the 2025 card beside the six other NIPERs and the shape is unmistakable. NIPER Kolkata's 84.73 for teaching, learning and resources is the highest of the seven, ahead of Guwahati at 84.30 and Raebareli at 81.76, while its 31.61 for research is the lowest of the seven, below Hajipur at 37.04 and far below Hyderabad at 74.10, all in the 2025 Pharmacy table. Whatever this campus is short of, the framework does not think it is teaching resource. What it has not produced at the rate its siblings do is research output, and for anyone choosing a research masters that is the parameter to put to a department by name.

Counting departments here gives different answers depending on which page you open, and the discrepancy has seats attached to it. The national brochure says the institute runs postgraduate programmes in ten departments, naming Medicinal Chemistry, Natural Products, Pharmacoinformatics, Pharmacology and Toxicology, Pharmaceutics, Pharmaceutical Analysis, Biotechnology, Biopharmaceuticals, Medical Devices and Medical Technology, in the Masters information brochure. The navigation menu that runs across the institute's own site, including its about page, names eight and ends at Biotechnology. The faculty page quietly adds a ninth, Biopharmaceutical, that the menu never shows.

So the largest single block on the counselling grid belongs to a department the institute does not describe anywhere on its own website. Twenty of the 120 seats are M.Tech. Medical Technology, in the seat matrix, and neither of the site's two department lists contains it, so no page names its head, its faculty or its laboratories. An allotment into Medical Technology is worth nothing until the department, the supervisor and the building behind it are named to you in writing.

Doctoral study is narrower than the taught list in a way that matters for anyone planning to stay on. Five subjects took doctoral places in the 2026 round, Medicinal Chemistry, Natural Products, Pharmacology and Toxicology, Pharmaceutics and Medical Devices, in the NIPER JEE 2026 Ph.D. seat matrix. Pharmaceutical Analysis, Pharmacoinformatics, Biotechnology, Biopharmaceuticals and Medical Technology took none through the entrance test that year, which is half the taught grid with no doctoral continuation on this campus under its own name.

The instrument park is run as a priced service and the rate card is public, which is the most concrete thing this institute publishes about its own capacity. Its Central Instrument Facility charges by experiment on the 400 MHz NMR: an academic user pays ₹650 a sample for proton work, ₹750 for a 13C or DEPT run, ₹850 for 19F and 31P and ₹1,700 for two dimensional experiments, against ₹1,300 to ₹3,400 for the same work booked by industry. Infrared spectroscopy is ₹750 against ₹2,500, flow cytometry without a sorter ₹2,100 an hour against ₹4,200, and the J-1500 circular dichroism spectrophotometer ₹1,700 for the first hour with ₹600 for each hour after it, all with 18% GST on top. The same page prices LC-MS work on a Q-Tof high resolution system and both analytical and preparative HPLC by the hour. An outside user can therefore find out what an hour of this campus costs, which is more than most institutes disclose.

Two centres explain where the research parameter is heading, and only one of them exists yet. The Centre for Marine Therapeutics sits on a five year project in affordable synthesis of expensive, complex drug molecules from marine sources, carrying 30 crore split 15 and 15 between the Department of Science and Technology and the Department of Pharmaceuticals, listed with Prof. V. Ravichandiran and Dr. S. P. Swain as investigators on the institute's projects page and described in the Masters information brochure as aimed at drug resistant cancers, bacteria and viruses. The second was announced at the Panihati ceremony as a Centre of Excellence in Flow Reactor and Continuous Manufacturing with 100 crore of Department of Pharmaceuticals funding, in the Press Information Bureau release of 25 August 2023. The 2026 admission brochure still says the institute is in the process of establishing that facility. A candidate drawn here by continuous manufacturing should ask what is actually running today.

Money is arriving faster than it is being spent on hardware, and the filing shows both lines. Sponsored research income more than tripled in a year, from ₹4,15,55,229 across 9 projects in 2023-24 to ₹14,87,34,160 across 12 in 2024-25, having stood at ₹3,67,52,527 across 7 in 2022-23, while spending on new laboratory equipment ran the other way over the same three years, ₹8,00,66,957, then ₹3,29,32,668, then ₹3,02,31,212, all in the NIRF 2026 data submission. Library capital spending rose to ₹96,49,020 in 2024-25 after ₹82,94,407 the year before. The output side of that money has only just started to show: patent publications went 1 in 2022, then 2 in 2023, then 8 in 2024, and 2024 is also the first calendar year in which any patent of this institute's was granted, at 2.

On accessibility the institute has given the same three answers two years running, and all three are at the top of the scale: more than 80% of buildings with lifts or ramps, more than 80% with specially designed toilets, and walking aids and inter-block transport available, in the NIRF 2026 and NIRF 2025 submissions. All three were given about one building at Maniktala. Panihati has not been built yet and the Salt Lake hostel is a separate property, so neither is described by that percentage.

The hostel is not on the campus and it is not near it. Students are accommodated at the NIPER hostel in IC Block, Sector III, Bidhannagar, Kolkata 700106, which is Salt Lake, and the institute runs a to and fro bus service between there and Maniktala, on its hostel page. The national brochure adds the part that costs money: this institute charges a miscellaneous fee for making those transport arrangements, over and above the hostel heads in the fee table. It is the only one of the seven NIPER sections in that brochure to carry such a note.

House rules here are stricter than the fee schedule suggests and they are published in full. Every resident is compulsorily a member of the hostel mess, rooms are allotted and cannot be swapped without the hostel supervisor's written permission, silence is required after 8:30 pm, and alcohol, intoxicants and smoking are banned outright inside the building, on the hostel page. Accommodation is offered on the availability of rooms and may be shared, per the Masters information brochure, and the institute posts its room allotment circulars for newly admitted students each session on its student corner rather than confirming a bed with the offer.

The teaching bench has shrunk while the student roll has grown, and the two filings say so plainly. The institute entered 39 faculty members in its NIRF 2025 data submission and 31 in its NIRF 2026 data submission a year later. Five of those 31 carry a leaving date, so 26 were in post when it was filed, against 206 masters students and 79 full time doctoral scholars in the same document. The institute's own faculty page shows 19 names, so read the filing rather than the website if you want the working number.

A third of that bench is borrowed, which the headcount alone will not tell you. The same filing marks 8 of the 31 entries as visiting and 3 more as adhoc or contractual, leaving 20 regular posts, two of which are held on a master's degree rather than a doctorate, in the NIRF 2026 data submission. Borrowing is how ten disciplines get covered on a campus this size. It also means the useful question for a department is not how many teachers it has but how many of them will still be here when your thesis is submitted.

One column in that filing is stark enough to plan around. Exactly 1 of the 31 faculty entries is recorded as a woman, and she is a visiting appointment whose leaving date is already entered, against 87 women among the 206 postgraduates on the roll, in the NIRF 2026 data submission. Put plainly, an incoming cohort that is more than two fifths women will be taught by a bench that has effectively none, and any applicant for whom that matters should establish which named person in her chosen department would supervise her before she accepts.

Leadership is the other thing that has moved, and the institute is openly looking for a replacement. The same filing carries Prof. V. Ravichandiran in the director's row with a joining date of 6 July 2015 and a leaving date of 8 October 2024, the director's page now names Dr. USN Murty in the post on additional charge while he continues as Director of NIPER Guwahati, and an advertisement for the post of Director of NIPER Kolkata sits in the vacancies list on the institute's own home page. The projects page meanwhile still lists Prof. Ravichandiran as principal investigator on the largest grants the campus holds, the 30 crore marine synthesis project among them. On recognition the institute publishes almost nothing: its awards page names a single honour, Dr. Satheesh Kumar Nanjappan of the Department of Natural Products as a Fellow of the Royal Society of Chemistry.

Reaching a former student of this institute means leaving its website. The alumni page does one thing, which is to hand you off to a separate portal at alumni.niperkolkata.edu.in; it describes an Office of Alumni Affairs and an Alumni Association but lists no office bearer, no batch roll and no directory, and it names no graduate at all.

Ceremonies are documented even where graduates are not. The convocation page carries papers for the fourth ceremony through the thirteenth, the oldest of them a magazine from the fifth convocation of 4 September 2017, and a list of medals for the twelfth convocation in 2024 sits among its student notices. The doctoral pipeline behind those ceremonies has thinned sharply: full time doctoral graduates numbered 9 in 2022-23, 7 in 2023-24 and 2 in 2024-25, in the NIRF 2026 data submission, while 79 scholars were on the roll. Two completions in a year against a doctoral school that size is the number to raise with a prospective supervisor.

Recruitment is what this institute has been publishing in 2026, and at pace. Its home page carries an advertisement for Phase 8 recruitment under employment notification NIPER-K/P-VIII/2026 dated 18 July 2026, one for Phase 9 under NIPER-K/P-IX/2026 dated 8 August 2026, and separate advertisements for the centre of excellence project seeking a chief executive, research associates and a junior research fellow. The same list carries a public notice warning candidates about fake recruitment advertisements. Three weeks between two general recruitment phases is what a campus does when it is filling posts, which cuts against the falling faculty count in its most recent filing.

The academic noticeboard runs to results and schedules rather than events. A schedule for physical reporting and document verification for the 2026-27 session heads the student corner, followed by fourth semester results for the 2024-26 postgraduate batch and first semester results for the 2025-26 doctoral batch. The news page is thinner still, with the 2026 holiday list posted on 8 December 2025, a One Nation One Subscription notice from 29 April 2025 and ministerial messages on Swachhata Pakhwada dated 31 August 2026.

Where the campus does gather people is around one subject in particular. Its photo gallery carries albums for both the fourth and the fifth Flow Chemistry and Natural Products Synthesis Symposium, alongside an international conference on chitosan held with the tenth Indian Chitin Chitosan Symposium, a symposium on drug delivery systems, a workshop on nucleic acids research and another on computational modelling and artificial intelligence. Flow chemistry appears twice in that list, which is consistent with the centre of excellence it is still trying to build.

Inside its own city, this institute is not the top ranked pharmacy address, and the gap has widened rather than closed.

Jadavpur University finished ahead in both of the last two tables, at 18 with a score of 64.14 in 2024 and at 24 in 2025. The two are not interchangeable, though, and the difference is not the ranking. Jadavpur admits school leavers to a pharmacy degree; this campus starts at masters level and takes only candidates who already hold a national fellowship scorecard. For a student finishing school in Kolkata this year, Jadavpur is the live option and this institute is a plan for four years later.

Comparing Kolkata with its own siblings is a narrower exercise, because one entrance paper, one fee schedule and one ₹12,400 stipend govern all seven, leaving only size and subject to separate them. Its 120 seats sit fifth of seven, ahead of Guwahati's 118 and Hajipur's 112 and behind Mohali's 244, Hyderabad's 210 and the 150 apiece at Ahmedabad and Raebareli, in the NIPER JEE 2026 seat matrix. On subject it is the only address in the country for M.Tech. Medical Technology and one of only three for Pharmacoinformatics, while a candidate who wants Pharmacy Practice, Regulatory Affairs, Regulatory Toxicology, Traditional Medicine, Clinical Research, Process Chemistry or any M.B.A. is ruled out here entirely, in the seat availability tables of the Masters information brochure.

None of the desks below can help with the entrance test, the merit list or a counselling round; all of that is Mohali's until an allotment letter exists. Everything from reporting day onwards is answered here.

The scientific neighbourhood is the real argument for this address, and it is a Kolkata neighbourhood rather than a national one. Of the twenty agreements on the institute's collaborations page, nine are with organisations in the city: CSIR-Indian Institute of Chemical Biology, the All India Institute of Hygiene and Public Health, the National Institute of Cholera and Enteric Diseases, Jadavpur University, Chittaranjan National Cancer Institute, Netaji Subhash Chandra Bose Cancer Hospital, the National Institute of Homeopathy, Bengal Chemicals and Pharmaceuticals Limited and TCG Life Science. The other eleven are scattered across the country, from CSIR-CDRI at Lucknow and CSIR-IGIB in Delhi to IIT Madras, Alagappa University at Karaikudi and IBSD at Imphal. Two cancer hospitals and a public health institute inside the same city is a set of collaborators no sibling campus can match, and for a pharmacology, toxicology or clinical project it is the difference between sending samples away and walking them across town.

At a glance

Quick facts